zepbound tirzepatide alternatives Eli Lilly sues companies selling alternative versions of its weight loss drug | KGOU Best Zepbound Alternatives In 2026:

Nearly two-thirds of people on the highest dose lost more than a fifth of their body weight

Weight loss outcomes : Semaglutide at the doses used for weight management (Wegovy, 2.4 mg weekly) has produced average weight loss of 15-17% of body weight over 68 weeks in clinical trials (STEP program)

The maintenance dose varies depending on individual response and tolerability, with maximum doses reaching 15 mg weekly for diabetes management

10.1016/j.biomaterials.2019.119281 33 HenryS.McAllisterD

Side effects compared Pretty similar, honestly

Pre-existing conditions like low blood pressure, heart disease, or neuropathy increase dizziness risk